🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

2,762 results for “CTI” Clear

  1. Lisdexamfetamine Dimesylate (LDX)

    Takeda

    Attention-Deficit Hyperactivity Disorder

    phase 1 small molecule completed

    1 trial

  2. Locametz 25 micrograms kit for radiopharmaceutical preparation, -, Pluvicto 1 000 MBq/mL solution for injection/infusion

    Novartis Pharmaceuticals

    Metastatic Castration-Resistant Prostate Cancer

    phase 1 small molecule active

    1 trial

  3. MARVEL algorithm

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrioventricular Conduction Block

    phase 1 other completed

    1 trial

  4. MCA-derived MSC therapy in renal transplant recipients

    Disc Medicine

    Rejection transplanted kidney, BPAR

    phase 1 other active

    1 trial

  5. MK-4646 Single Ascending Dose Study and DDI in Healthy Participants

    Merck Sharp and Dohme

    HIV infection

    phase 1 other active

    1 trial

  6. MSC-derived exosomes

    Regeneron Ireland Designated Activity Company (DAC)

    Long COVID-19 Syndrome

    phase 1 mab active

    1 trial

  7. MSD-001

    Lxo Ireland Designated Activity Company

    Mental Health Disorders

    phase 1 small molecule completed

    1 trial

  8. MV-LASV

    Harmony Biosciences Holdings

    Lassa Virus Infection

    phase 1 mab completed

    1 trial

  9. MarzAA (marzeptacog alfa [activated])

    CATALYST PHARMACEUTICALS, INC.

    Hemophilia A

    phase 1 mab completed

    1 trial

  10. Mifepristone 300 MG

    CORCEPT THERAPEUTICS INC

    Drug Interaction Potentiation

    phase 1 small molecule completed

    1 trial

  11. Modified Gegen Qinlian Decoction

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ulcerative Colitis

    phase 1 small molecule active

    1 trial

  12. NDV-3 vaccine with alum IM

    United Therapeutics Europe Ltd

    Staphylococcal Infections

    phase 1 mab completed

    1 trial

  13. NFC-1

    Avalo Therapeutics

    Attention-deficit Hyperactivity Disorder (ADHD)

    phase 1 small molecule completed

    1 trial

  14. NFC-1 100 mg

    Avalo Therapeutics

    Attention Deficit Disorder With Hyperactivity

    phase 1 small molecule completed

    1 trial

  15. NGGT002 Injection

    The First People's Hospital of Lianyungang

    Phenylketonurias

    phase 1 gene therapy active

    1 trial

  16. NM1F Injection

    TG THERAPEUTICS, INC.

    Ovarian Cancer

    phase 1 small molecule active

    1 trial

  17. Nemonoxacin

    Jian Li

    Kidney Dysfunction

    phase 1 small molecule active

    1 trial

  18. NeoTISLEGA - A phase Ib trial evaluating the safety and activity of neoadjuvant combination of tislelizumab plus FLOT for resectable esophagogastric adenocarcinoma

    The George Institute

    resectable esophagogastric adenocarcinoma

    phase 1 other active

    1 trial

  19. Nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Addiction

    phase 1 small molecule completed

    1 trial

  20. Nicotine (Pharmaceutical Productions Inc.)

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Pharmacokinetic Study

    phase 1 small molecule completed

    1 trial

  21. Nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Addiction

    phase 1 small molecule completed

    1 trial

  22. Normal Saline (NS) .9% 10 mL Injection

    Blackmores Limited

    Ovarian Failure

    phase 1 small molecule active

    1 trial

  23. Novel restraint

    Lxo Ireland Designated Activity Company

    Acute Respiratory Failure

    phase 1 other completed

    1 trial

  24. Olanzapine Extended Release

    Teva Pharma GmbH

    Schizophrenia, Schizoaffective Disorder

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources